Search Our Website:

Mike Strazzella, head of the firm's Federal Government Relations Practice Group and healthcare industry group leader, comments on potential legal challenges of the Trump administration's proposed transparency rules regarding drug pricing in Fierce Healthcare's article "Hospitals Get Ready to Fight CMS in Court Again, This Time Over Transparency."

“This is going to be a clear case of whether this is going to be a violation of antitrust law,” said Mike Strazzella, head of federal government relations at the law firm Buchanan Ingersoll and Rooney. “The underlying theme of antitrust law is based on your own negotiation, not on what other people are doing.”